Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00266331 | RayGel-An Alternative for Skin Care During External Beam Radiation | PHASE2 | COMPLETED | 150 | — | — | Oct 1, 2004 | May 1, 2011 | Aug 28, 2013 | 1 | United States |
Skin reaction scale along with evaluation by radiation oncologist at weekly intervals from start of radiation therapy until completion of radiation.
| Arm | Type | Description |
|---|---|---|
| Group A, RayGel Topical Cream | ACTIVE_COMPARATOR | RayGel Topical Cream applied in thin layer to the area exposed to radiation 60-90 minutes prior to radiotherapy, standard skin care between treatments. |
| Arm B Placebo Topical Cream | PLACEBO_COMPARATOR | Placebo Topical Cream applied in thin layer to the area exposed to radiation 60-90 minutes prior to radiotherapy, standard skin care between treatments. |
| Name | Type | Description |
|---|---|---|
| Reduced glutathione | DRUG | - |
Inclusion Criteria: 1\. Breast Cancer * Radiation Exclusion Criteria: 1. Post Mastectomy 2. Previous irradiation of the same breast 3. Pregnacy 4. Younger than 18 years of age